GLP-1/GIP Uptake, Indication, and Access Pathways Among US Adults in the Understanding America Study
medRxiv
Abstract
ImportanceEvidence on GLP-1/GIP therapies is largely derived from trials enrolling selected populations or medical records that miss utilization outside healthcare channels. No nationally representative cohort has characterized real-world uptake, indications, and access.
- GLP-1 receptor agonists
- GLP-1 and incretin signalling
- Diabetes mellitus
- Obesity
- Heart rate variability
- Humans
The paper
Ritika R. Chaturvedi, Tadeja Gračner, Francisco Pérez‐Arce, Arie Kapteyn
Show 6 more authors
Sze‐chuan Suen, Jing Jin, Bart Orriens, Rosalie Liccardo Pacula, Alison Sexton Ward, Rebecca Haile,University of Southern California
medRxiv · 2 Sep 2026 · CC BY · Preprint, not peer-reviewed